Thanks Lex, I actually just wrote my thoughts in the thread. But I agree. I'm balls deep but almost in the green again on AHZ, so if growth continues the next two days I'll be in a good position to take advantage of whatever happens. You're right though, I want to see decisive action on the Immunotherapies division, including getting rid of it if the Vax is a dud. I don't want to see another 5 years of funding through CR for a HPV vaccine. Palm it off to someone else if it is a dud (it might not be).
This would be very beneficial to AHZs bottom line over the next 6 months.
If it's not a dud and there's a deal in the offing, well then we have nothing to worry about.
Ann: HSV-2 Phase IIa Results Investor Webinar, page-130
-
- There are more pages in this discussion • 167 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$9.99 |
Change
-0.910(8.35%) |
Mkt cap ! $211.1M | |||
| Open | High | Low | Value | Volume |
| $10.50 | $10.79 | $9.30 | $1.477M | 149.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2000 | $9.70 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $9.99 | 1999 | 1 |
View Market Depth
| Last trade - 16.10pm 06/09/2024 (20 minute delay) ? |
| AVR (ASX) Chart |